Several recent studies have identified species differences and validated molecular mechanisms using human sensory neurons, but few have provided a detailed description of extraction or culturing methodologies [18] [19] [20] [21] . Here we provide a detailed surgical extraction protocol for postmortem access to hDRG immediately after organ procurement from donors who provided consent. We have used this protocol previously to extract and culture hDRG for studies investigating mGlu2 function in human sensory neurons 22 . Our ventral approach through the abdominal cavity eliminates the need to move the donor during the procedure and preserves the structural integrity of the body, thus considerably reducing postmortem interval for DRG retrieval and resulting in minimal interference with other surgical procedures. Maintaining a sterile intraoperative field during the extraction allows subsequent tissue procurement of bone and skin, ensuring maximal utilization of donor tissues by OPOs. This approach maintains the overall integrity of the donor body for funeral purposes, and it allows access to all donors who consent to tissue donation for research.
IntroDuctIon
Primary cultures of dissociated rodent sensory neurons are widely used in preclinical studies of pain, itch, nerve injury, regeneration and axonal transport. Many candidate molecular targets and genes have been identified using this approach, yet few of these findings have directly translated into effective and safe clinical treatments [1] [2] [3] [4] [5] . Several notable failures in translation have raised questions about possible differences in fundamental biological mechanisms between humans and rodents [6] [7] [8] [9] [10] [11] [12] . For example, NK1 receptor antagonists failed to provide significant analgesia in humans, despite strong preclinical effects in rodents 6 . More recently, the Mas-related G-protein-coupled receptor (Mrgpr) subtypes a3 and c11 were discovered to be key mediators of acute and chronic itch in mice, but are not conserved in humans, which instead have four MRGPRX receptors (MRGPRX1-4). Human MRGPRX1 can be activated by both Mrgpra3 and Mrgprc11 agonists, although key differences in the pharmacological profiles of these receptors demonstrate distinct molecular mechanisms in mice versus humans [13] [14] [15] [16] [17] . In support of these fundamental biological differences, GABA A -receptor-mediated currents in cultured human sensory neurons were recently found to exhibit distinct biophysical features from those in rodents, demonstrating the importance of this type of preclinical approach 18 .
By using this protocol, we have obtained DRG from multiple spinal levels and have used this opportunity to culture from half of the ganglia, while preserving the remaining tissue for mRNA and immunohistochemical analysis. This permits parallel functional and gene expression studies from the same donor with the ability to correlate observations with patient medical information 19, 21, 22 . We have also transduced cultured hDRG with viral vectors for expression of light-sensitive proteins for optogenetic applications, which enables the manipulation of sensory neuron activity with light [23] [24] [25] . We anticipate that by adapting these approaches preclinical mechanisms of altered sensory processing can be directly verified in human neurons, facilitating the identification of new therapeutic targets and clinically effective treatments.
of substantially larger tissues with more abundant connective tissue than rodent DRG 22. Notable differences between this protocol and those previously described include the specific types of enzymes used (papain versus trypsin and DNase 18 , or proprietary enzyme mixture 19, 21 ) and the duration of enzymatic digestion (up to 3.5 h in some studies). The type of culture medium and use of neurotrophic factors has also varied between studies, with several using DMEM/F12-based medium and all studies supplementing the medium with varying concentrations of nerve growth factor (NGF) and/or glial cell line-derived neurotrophic factor (GDNF). The successful culturing of human cells in a variety of different culture media and following different digestion methodologies suggests that individual labs may be able to adapt this protocol. Producing viable cultures of adult human sensory neurons using conditions similar to those used in previous studies of rodent neurons should reduce sources of variation and allow for direct comparison between rodent and human sensory neurons.
Recent advances in induced pluripotent stem cell (iPSC) methods have produced nociceptor-like cells derived from human fibroblasts that express transient receptor potential (TRP) channels and can be sensitized by inflammatory mediators such as prostaglandin E 2 (PGE 2 ) (refs. 33, 34) . Unlike sensory neurons obtained from organ donors, neurons generated using such methods are not restricted by donor availability, because they do not rely on postmortem tissue collection and can be further strengthened by a living donor's developing medical history. However, the iPSC approach is still limited by low nociceptor conversion rates (<5%) and the use of varying transcription factor combinations to produce nociceptor-like populations. Although both approaches can be informative, direct studies in human sensory neurons may more accurately recapitulate the complex overlapping sensory neuron subpopulations and downstream signaling cascades involved in sensory processing.
Applications of the method
Cultured human sensory neurons can serve as a valuable tool in functional and genetic studies to validate the numerous molecular targets identified in animal models. By using patch-clamp recordings, calcium imaging, immunohistochemistry, gene knockdown and viral gene transfer, the fundamental physiological properties of human sensory neurons can be more accurately characterized. These approaches could lead to the discovery of new target receptors or channels, and they allow for in-depth characterization of pharmacological agents in native human cells. Whole ganglia or cultured neurons can help identify human biomarkers for chronic pain and itch through advanced approaches in RNA and whole-genome sequencing, which can be further strengthened by available donor medical history. Furthermore, the potential of novel therapeutic interventions involving gene therapies, and optogenetic and chemogenetic manipulations of cellular activity, can be verified directly in human sensory neurons.
Limitations
An important challenge to obtaining viable hDRG cultures is the identification of a local transplant service or OPO that can provide immediate access to their operating room, once vital organs are removed for transplantation. Minimizing the postmortem interval for DRG procurement is crucial for optimal neuron health, but it will be directly dependent on the duration of organ procurement. The frequency of suitable donor availability will vary depending on the institution and inclusion criteria. Factors related to donor medical history, age, sex, ethnic background and body mass index may introduce variability and should be considered during analysis when averaging data from multiple donors. Primary cultures of human sensory neurons probably present the same caveats that are inherent to all dissociated primary cultures, the most notable of which is axotomy. During the dissociation process, the peripheral and central processes of the neurons are severed, resulting in the activation of injuryand regeneration-associated cascades. To address this potential confound, the expression pattern of proteins or genes of interest can be directly compared between intact ganglia and cultures of neurons from the same donor and spinal level. The specific culturing protocol that we describe can produce live adult sensory neurons that are amenable to physiological and biochemical measures and are similar to those studied in our previous publications 21, 22 . However, an extensive characterization of specific neuronal subpopulations is not provided. Despite these limitations, dissociated cultures of human sensory neurons are a valuable resource that enables the precise manipulation of external factors to study neuronal physiology specific to humans.
Overview of the procedure
The key stages of this protocol are extraction of hDRG from an organ donor, cleaning of ganglia, enzymatic and mechanical dissociation, and isolation and plating of dissociated neurons. hDRG extraction takes place in the operating room of the OPO or transplant service, where access to tissue can be obtained once vital organs have been removed from organ donors who had provided consent. After procurement, hDRG are stored in N-methyl-d-glucamine (NMDG) artificial cerebrospinal fluid (aCSF) solution for transport, cleaning and enzymatic digestion. NMDG-based aCSF solutions reduce neuronal permeability to sodium and calcium, reduce oxidative stress and are very beneficial for producing adult rodent brain and spinal cord slices for electrophysiological recordings [35] [36] [37] [38] . Upon return to the laboratory, DRG are cleaned of connective tissue and fat, dura mater is removed and nerve roots and rami are trimmed. The remaining ganglion is finely cut and enzymatically digested before mechanical dissociation. Sensory neurons are isolated from large debris by filtration and centrifugation, and then they are plated on poly-d-lysine (PDK)-and collagen-coated glass coverslips.
Experimental design
Access to human donor tissue. This protocol provides investigators seeking to establish partnerships with transplant services or OPOs a clear roadmap and the specific details for extraction of human sensory neurons. After establishing contact with a local OPO or transplant service, investigators will need to obtain the appropriate regulatory documentation and agreements, including institutional review board waivers and documentation of donor or family consent to tissue donation for research. The logistics in establishing a network for donor notification, the timing for the research team preparation and access, and the surgical tools to be used must be coordinated with the OPO or transplant service. Since establishing this approach at our institution, we have had access to donor tissue approximately once per month. When a donor becomes available and consent has been obtained for tissue donation to research, we are contacted by our collaborator MidAmerica Transplant, generally 3-8 h before organ procurement.
Cell yield. The total number of coverslips obtained for functional studies will depend on the number of ganglia cultured and cell density needed for a particular study. We have found that one DRG can produce ~10-12 coverslips plated at a density of 500 cells per coverslip. However, this can vary based on several factors, including DRG size (L1 is smaller than L2-4), degree of dissociation and general health of the tissue. The density of 500 cells per coverslip provides an optimal number of cells for calcium imaging studies (~20-30 cells per viewing field at a 10× magnification) without excessive debris. Alternatively, plating density can be adjusted to fit investigator needs. For example, plating at a lower density of 200 cells per coverslip was suitable for electrophysiological recordings and immunocytochemical techniques, but it did not provide robust numbers for calcium imaging studies.
Growth factors (optional).
Human NGF (25 ng/ml) and human GDNF (25 ng/ml) may be included in the medium based on the experimental design of the investigator 21 . We have found that cells cultured without growth factors survive for >10 d and can be used for electrophysiological recordings and calcium imaging, without measurable effects on membrane properties (unpublished observation). The ability to maintain these neurons in culture in the absence of growth factors allows for future studies to determine the acute effects of growth factors on receptor expression or sensitization.
Culturing methods. This culturing protocol follows our prior published studies very closely, using the same coverslip coating solution, digestive enzymes and culture medium [26] [27] [28] [29] [30] [31] [32] . Following these procedures will produce viable dissociated cultures of hDRG neurons, but recent publications indicate that it may also be possible to culture human sensory neurons in the presence of other types of culture media 18, 19, 21 . Investigators may decide to incorporate the same enzymatic digestion, plating protocol or culture media that they have previously used in animal model studies if the goal is to make direct comparisons to those prior studies. In such cases, our protocol can provide a positive control to confirm the viability of neurons as investigators adopt the extraction and dissection procedures in their own laboratories. KCl (Sigma-Aldrich, cat. no. P5405-250G) NaH 2 PO 4 (Sigma-Aldrich, cat. no. S5011-100G) NaHCO 3 (Sigma-Aldrich, cat. no. S5761-1KG) HEPES (Sigma-Aldrich, cat. no. H4034-500G) d-(+)-Glucose (Sigma-Aldrich, cat. no. G8270-1KG) l-Ascorbic acid (Sigma-Aldrich, cat. no. A5960-25G) Thiourea (Sigma-Aldrich, cat. no. T8656-50G) ! cautIon Thiourea is a potential carcinogen, and it may cause irritation to the eyes, skin and respiratory tract. Wear gloves, lab coat and safety goggles when you are handling thiourea solution. Na + pyruvate (Sigma-Aldrich, cat. no. P2256-25G) MgSO 4 (2 M; Fisher, cat. no. BP213-1) REAGENT SETUP PDK solution Dissolve 5 mg of PDK in 50 ml of sterile water and prepare 1-ml aliquots (0.1 mg/ml); store the solution at −20 °C. This solution can be used for up to 1 year. Collagen solution Dissolve collagen in sterile water for a final concentration of 1 mg/ml, store it at 4 °C and use it within 2-3 months. PDK/collagen solution Combine 1 ml of 0.1 mg/ml PDK, 2 ml of 1 mg/ml collagen and 7 ml of sterile water. The final concentration is 0.01 mg/ml PDK and 0.2 mg/ml collagen. Store it at 4 °C and use it within 2-3 months. l-Cysteine Dissolve 20 mg of l-cysteine into 1 ml of sterile HBSS to make 1 mg per 50-µl aliquots. Store the solution at 4 °C. Use it within 6 months.
MaterIals

REAGENTS
Papain Calculate the number of active units (U) per ml of enzyme solution and add 45 U per tube. Store it at 4 °C for up to 6 months. Collagenase Dissolve 100 mg of collagenase in 4.5 ml of HBSS. Prepare 200-µl aliquots of enzyme solution per tube (4.5 mg) and store them at −20 °C. This solution can be used up to 6 months. DRG medium (100 ml) Combine 1 ml of penicillin/streptomycin, 2 ml of B27 supplement, 5 ml of FBS, 1 ml of GlutaMAX and 91 ml of Neurobasal A. Filter-sterilize the medium using a vacuum pump, and prepare aliquots in 50-ml conical tubes. Store the solution at 4 °C protected from light for up to 2 weeks. NMDG-aCSF solution Combine the reagents listed in the table below in 450 ml of Milli-Q H 2 O in the order listed. Adjust the pH to 7.4 with NMDG/HCl and osmolarity to 300-310 mOsm, if necessary, with H 2 O or sucrose 35, 36 . proceDure removal of hDrG from spinal column • tIMInG 20-30 min ! cautIon Sterile operating room procedures need to be followed for tissue extraction. Exercise proper safety precautions (e.g., gloves, eye protection, scrubs and lab coat) when you are working with human tissues.  crItIcal The following steps can be performed with the internal organs retracted, but the procedure is considerably easier if all viscera are removed. The dissection tools (with the exception of the Stryker autopsy bone saw) used below were made available for this extraction protocol in the operating room. Investigators should discuss with their OPO or transplant service whether they need to provide their own instruments. 1| Prepare several (6-10) 40-ml aliquots of NMDG-aCSF solution in air-tight 50-ml conical tubes wrapped in Parafilm, and maintain them on ice for hDRG transport after extraction. Continue to bubble the remaining NMDG-aCSF solution on ice for hDRG dissection.
Reagent
2|
Expose the lumbar spinal column using a scalpel to remove abdominal vasculature and connective tissue located anterior to the spine in the retroperitoneal space (this includes the abdominal aorta, inferior vena cava, lymphatics and so on).
3| By using a scalpel, cut and retract or remove psoas major and psoas minor muscles from their origin and expose the lateral aspects of the spinal column and the roots of the lumbar plexus.
4|
Using a mallet and straight osteotome, transect L1 and L5 vertebral bodies, by stopping at the spinal canal (Fig. 1a) .
? trouBlesHootInG 5| Transect the pedicles bilaterally between L1 and L5, by staying close to the posterior edge of the vertebral bodies, but anterior to the spinal canal (Fig. 1b) . If you are using a sterile mallet and curved osteotome, use a scalpel or dissecting scissors to detach the dura mater from the posterior longitudinal ligament to minimize tearing and pulling of the DRG when the vertebral bodies are removed. If you are using an autopsy bone saw, the blade is wide enough to cut the posterior longitudinal ligament, preventing tearing of the dura mater in Step 12 without the need to use a scalpel.  crItIcal step If you are using a sterile mallet and curved osteotome to perform this step, the sterility of the surgical field is maintained, but they do not offer the more precise cutting of a bone saw and require much more manual power. The autopsy saw allows for more rapid and precise identification of spinal levels; however, it cannot be sterilized, and therefore it will compromise the sterile surgical field. Therefore, its use is limited by OPO or transplant service procedures for tissue retrieval after hDRG extraction (alternatively, surgical grade micro-saws that can be sterilized may be used, but they are considerably more expensive).
? trouBlesHootInG 6| Manually remove the entire anterior portion of the vertebral column between L1 and L5; lift carefully to minimize tearing of structures in the intervertebral foramina and simultaneously cut any dural attachments to the posterior longitudinal ligament. Ensure that the transverse processes, laminae and spinous processes remain in place (Fig. 1c) .  crItIcal step It is essential to leave the dorsal portion of the vertebral column intact to maintain the integrity of the body for further tissue procurement and funeral service purposes. This is a major concern for potential partnering transplant services or OPOs.
? trouBlesHootInG 7| Gently tug on the dura mater to visualize the DRG, and dissect each ganglion away from surrounding connective tissue and bone using DeBakey pick-ups and dissecting scissors. Cut the spinal roots and rami of peripheral nerves to completely free the DRG (Fig. 1d) . ? trouBlesHootInG 8| Rinse DRG in 40 ml of ice-cold NMDG-aCSF, and place it in 40 ml of fresh ice-cold NMDG-aCSF in air-tight 50-ml conical tubes. Maintain the tubes on ice for transport.
cleaning of DrG • tIMInG 30-90 min ! cautIon Exercise proper safety precautions when you are working with, and disposing of, materials containing human tissues. All procedures need to be performed using sterile technique in biosafety cabinets, and tools must be properly cleaned and sterilized after every use. 9| Place individual DRG in a 60-mm Petri dish filled with 15-20 ml of ice-cold NMDG-aCSF to fully submerge the ganglion, and keep the Petri dish on ice for the duration of cleaning and dissection.
10| Using large spring scissors and forceps, remove remaining fat and connective tissue surrounding DRG (Fig. 2a) .
11|
Under a dissection microscope, use Dumont no. 5 forceps and large spring scissors to identify the edge of the dura along the severed ends of the central and peripheral nerve processes. Cut the dura longitudinally from the peripheral to the central endings.
12|
Remove dura by continually pulling away from the ganglion and cutting along the edge where the dura meets the DRG and nerves (Fig. 2b) . 13| Trim the remaining central and peripheral nerve processes with a scalpel, so that only the ganglion body remains (Fig. 2c) 
22|
Remove most of the NMDG-aCSF solution, leaving ~100 µl, and add 2 ml of prewarmed DRG medium. ? trouBlesHootInG 23| Gently triturate the tissue through the fire-polished tip of a sterile glass Pasteur pipette until the solution becomes cloudy and little resistance remains (~10-20 times). Tissue from younger donors will require less trituration than older donors.  crItIcal step Do not over-triturate, and take care not to generate bubbles during trituration.
? trouBlesHootInG Carefully pass the solution of dissociated neurons through a 100-µm sterile filter into a 50-ml conical tube.  crItIcal step hDRG neurons are approximately twice the diameter of dissociated sensory neurons from rodents, and filters traditionally used for rodent cultures will not be suitable. Although most rodent studies can be completed within 24 h of cell plating, human sensory neurons are often tightly encased by satellite glia until the third or fourth day in vitro (DIV). During these first days in culture, glial cells peel off, thus allowing membrane access for patch pipettes or direct fluorescence visualization (Fig. 3) . More vigorous dissociation protocols can yield neurons free of supporting glia, but the health and survival of these neurons may be reduced 21 .
The neurons produced with this extraction and dissociation protocol can be maintained in culture for >10 d 22 .
Immunocytochemical studies of human sensory neurons
Whole ganglia and dissociated neurons can be studied using validated antibodies and standard immunocytochemical techniques to characterize cell morphology, and localization and expression of ion channels, receptors and intracellular proteins (Fig. 4) Population-wide responses to chemical or thermal stimuli can be characterized using calcium imaging procedures that we have previously published 26, 30, 31 . Primary cultures of dissociated human sensory neurons were loaded with the calcium indicator Fura2-AM (Life Technologies), and individual neuronal responses to several bath-applied stimuli were measured (Fig. 5) . Waiting until the satellite glia have moved off the neurons to expose the soma (Fig. 3c) is important for obtaining neuron-specific calcium signals, as glia are also labeled by Fura2 dyes. Calcium imaging recordings on DIV4-7 demonstrate labeled neurons that are much larger than surrounding glial cells (Fig. 5a ). An intracellular increase in calcium was visualized in subsets of neurons during application of the pruritogens histamine and chloroquine (Fig. 5a) , and the algogens mustard oil, menthol and capsaicin (Fig. 5b) . showing an en-passant-type presynaptic enlargement (synapsin, red) that formed along a sensory axon (tau, green) (g-i). Scale bars, 50 µm (a-f) and 5 µm (g-i). Antibodies used in immunocytochemistry experiments include the following: rabbit anti-TRPV1 (1:800), custommade serum directed against the TRPV1 C-terminal peptide CLKPEDAEVFKDSMVPGEK, specificity confirmed in TRPV1 −/− mice 30, 43 ; mouse anti-βIII-tubulin (1:2,000, EMD Millipore cat. no. 05-559, species reactivity (hm/bv/rat/ms), antibody registry ID: AB_309804); guinea pig anti-GFAP Human sensory neurons obtained using this protocol can also be studied using patch-clamp electrophysiology techniques. Gigaohm seals were obtained from >95% of selected neurons. We were careful to only patch neurons with a clearly . KCl (50 mM) was added at the end to confirm viability. Example traces from a separate experiment demonstrate that dissociated neurons (b, left) also responded to the algogens mustard oil (100 µM), menthol (100 µM) and capsaicin (200 nM). Scale bars, 100 µm. CQ, chloroquine.
